Cilostazol

• Supplier: Tocris Bioscience
• Catalog: 0915
• Prices: $189.00
• Sizes: 10 mg
• Function Type: Inhibitor
• Cas Number: 73963-72-1
• Chemical Name: 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
• Formula: C20H27N5O2
• Molecular Weight: 369.47
• Purity: >99 %
• Description: Potent phosphodiesterase III A (PDE3A) inhibitor (IC 50 = 0.2 μ M) and inhibitor of adenosine uptake. Has antimitogenic, antithrombotic, vasodilatory and cardiotonic properties in vivo . Also affects lipid levels in vivo .

Product References

General pharmacological properties of cilostazol, a new antithrombotic drug. Part - General pharmacological properties of cilostazol, a new antithrombotic drug. Part

Shintani S, Toba Y, Suzuki S, Ninomiya S, Umezato M, Hiyama T. Arzneimittelforschung. 1985;35(7A):1157-62.

General pharmacological properties of cilostazol, a new antithrombotic drug. Part - General pharmacological properties of cilostazol, a new antithrombotic drug. Part

Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S, et al.. Arzneimittelforschung. 1985;35(7A):1163-72.

The pharmacology of cilostazol. - The pharmacology of cilostazol.

Schror K. Diabetes Obes Metab. 2002 Mar;4 Suppl 2:S14-9.